Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Prolia on Bone Density
IRCT20191030045282N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of denosumab in low bone mineral density, sponsored by Alborz University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
denosumab
03
Conditions
low bone mineral density
Beyond the preview
Go deeper on IRCT20191030045282N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191030045282N1.